Themed collection Sustainable Medicinal Chemistry

7 items
Open Access Opinion

The many facets of sustainability in medicinal chemistry: our personal experience

Sustainability cannot be an afterthought; it must be embedded into every framework of medicinal chemistry.

Graphical abstract: The many facets of sustainability in medicinal chemistry: our personal experience
From the themed collection: Sustainable Medicinal Chemistry
Review Article

From lab to environment: forecasting pharmaceutical impact using in silico and analytical tools

This review highlights in silico tools (QSAR, machine learning, molecular docking) and advanced analytical methods, including ion mobility spectrometry, for predicting and validating pharmaceutical persistence, toxicity, and bioaccumulation.

Graphical abstract: From lab to environment: forecasting pharmaceutical impact using in silico and analytical tools
From the themed collection: Sustainable Medicinal Chemistry
Review Article

Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products

Biocatalysis has ascended as a defining force in contemporary total synthesis, furnishing catalytic modalities that deliver molecular complexity with unparalleled chemo-, regio-, and stereo-control.

Graphical abstract: Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products
From the themed collection: Sustainable Medicinal Chemistry
Open Access Research Article

Integrating green synthesis and liquid–liquid extraction of lidocaine in deep eutectic solvents

A DES-to-DES process enables one-pot lidocaine synthesis with solvent-free isolation, while eutectic media serve as reaction solvents, extraction agents and formulation platforms, enabling reduced PMI and greener pharmaceutical processing.

Graphical abstract: Integrating green synthesis and liquid–liquid extraction of lidocaine in deep eutectic solvents
From the themed collection: Sustainable Medicinal Chemistry
Research Article

Oxyprenyl–chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction

The escalating threat of antimicrobial resistance (AMR) compels the development of novel antibiotics with broad spectrum activity and environmentally responsible degradation profiles.

Graphical abstract: Oxyprenyl–chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction
From the themed collection: Sustainable Medicinal Chemistry
Research Article

Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action

Tanshinone I, IIA, and cryptotanshinone from Salvia miltiorrhiza inhibit M. tuberculosis, including resistant strains, showing low toxicity, high selectivity, and potential cell wall targeting suggested by morphological and genomic analyses.

Graphical abstract: Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action
From the themed collection: Sustainable Medicinal Chemistry
Open Access Research Article

Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach

Microwave-assisted synthesis of new pyrrole and indole derivatives as tubulin assembly inhibitors was performed with remarkably improved yields and short reaction times.

Graphical abstract: Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach
From the themed collection: Sustainable Medicinal Chemistry
7 items

About this collection

This collection, guest edited by Professor Maria Laura Bolognesi (University of Bologna), Professor Daniele Castagnolo (University College London) and Dr Magnus Johansson (AstraZeneca), highlights the emerging trend of sustainability concepts permeating the early preclinical phase of the pharmaceutical development pipeline with the pressing aim of discovering benign-by-design drugs. It brings together the latest developments in sustainability specifically related to medicinal chemistry including green chemistry, use of continuous processes, enzymes/microorganisms and renewable resources for synthesis of hits, leads and drug candidates, late-stage functionalisation methodologies for library assembly, property-related metrics for ecotoxicology and design of biodegradable drugs.
New articles will be added to the collection upon publication. Please return to this page frequently to see the collection grow.

Spotlight

Advertisements